South Africa 1991a.
Methods | Allocation concealment: cards labelled R and Q picked blindly from a box, these identified drug container. Two arms | |
Participants | 32 women at 12 to 30 weeks' gestation with a singleton pregnancy and BP >/= 140/90 mmHg x 2 at least 6 hrs apart, no proteinuria, no antihypertensive therapy and no other drug treatment. | |
Interventions | Exp: oral prazosin 1 mg to 5 mg x 3/day. (12 women) Control: oral identical placebo. (20 women) | |
Outcomes | Women: severe HT, proteinuria, duration of treatment, placental abruption, caesarean section. Babies: perinatal death, gestation at delivery (mean), birthweight, SGA (< 10th centile) preterm delivery (< 37 weeks). | |
Notes | Method for measuring BP not mentioned. The trial stopped early. Funding: no information about funding source. Declaration of interests not described. |
|
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Random sequence generation (selection bias) | Unclear risk | Not described. |
Allocation concealment (selection bias) | Unclear risk | Not described. Quote: "...in a randomised way, participants either received...". No further details. |
Blinding of participants and personnel (performance bias) All outcomes | Unclear risk | Although identical placebo tablets were used, there is no information about whether it was a double‐blind or a single‐blind trial. |
Blinding of outcome assessment (detection bias) All outcomes | Unclear risk | Not described. |
Incomplete outcome data (attrition bias) All outcomes | Low risk | No. |
Selective reporting (reporting bias) | Unclear risk | Assessment from published study report. |
Other bias | Unclear risk | No information about funding source. Declaration of interests not described. |